Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
An update from Codexis ( (CDXS) ) is now available.
Codexis, Inc. has appointed Raymond De Vré as a new Class I director to its Board, enhancing its leadership with a seasoned executive experienced in biotech and pharmaceuticals. Dr. De Vré will also join the Science and Technology Committee, bringing expertise from his tenure at RADV Advisory and PolyPeptide Group. Alongside this, Codexis has updated its bylaws to align with Delaware law and refine stockholder meeting procedures, signaling a strategic governance enhancement.
Learn more about CDXS stock on TipRanks’ Stock Analysis page.
